Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment
about
Lung Microbiota and Its Impact on the Mucosal Immune Phenotype.Changes in microbiome during and after travellers' diarrhea: what we know and what we do not.Gut microbiota-mediated protection against diarrheal infections.Effects of short- and long-course antibiotics on the lower intestinal microbiome as they relate to traveller's diarrhea.Characterization of Metagenomes in Urban Aquatic Compartments Reveals High Prevalence of Clinically Relevant Antibiotic Resistance Genes in Wastewaters.In Situ Analyses Directly in Diarrheal Stool Reveal Large Variations in Bacterial Load and Active Toxin Expression of Enterotoxigenic Escherichiacoli and Vibrio cholerae.Metaviz: interactive statistical and visual analysis of metagenomic data.BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection.Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.Dosing Regimen of Enrofloxacin Impacts Intestinal Pharmacokinetics and the Fecal Microbiota in SteersEffects of Psychological, Environmental and Physical Stressors on the Gut MicrobiotaProliferation of enterotoxigenic strain TW11681 in stools of experimentally infected human volunteers
P2860
Q33833225-C2948092-282C-4F94-B163-7E5742B92BB1Q38682285-03ABF737-AB98-4702-A949-82F2ADD61952Q38776970-23114091-42B5-4F48-BB59-B5741F463093Q38776974-1D70AB1C-53E2-469B-A43B-67476DB6C656Q46248867-EE48B067-7FA3-40DA-9E34-C72996019255Q48102113-C53185E7-ABA8-49B2-BE31-5F61BDAD3950Q53079633-7B1AD8B0-72C8-4905-9A91-ABA563DB6AC3Q53686005-91D54173-14F2-4C9B-A9CC-B67FE5460C31Q55322314-D190B7ED-149E-4B30-AEC2-5BDD59A88DD5Q57072811-BB3C8D21-5D8C-455D-AE7A-ED7A7BFE0022Q57091526-699D6164-47F4-4EDD-A9F5-D146625A0CF9Q57814275-6A0018CB-8340-4C6C-A95D-32D320B49D94
P2860
Individual-specific changes in the human gut microbiota after challenge with enterotoxigenic Escherichia coli and subsequent ciprofloxacin treatment
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Individual-specific changes in ...... equent ciprofloxacin treatment
@ast
Individual-specific changes in ...... equent ciprofloxacin treatment
@en
type
label
Individual-specific changes in ...... equent ciprofloxacin treatment
@ast
Individual-specific changes in ...... equent ciprofloxacin treatment
@en
prefLabel
Individual-specific changes in ...... equent ciprofloxacin treatment
@ast
Individual-specific changes in ...... equent ciprofloxacin treatment
@en
P2093
P2860
P50
P1433
P1476
Individual-specific changes in ...... equent ciprofloxacin treatment
@en
P2093
Brianna R Lindsay
Clayton Harro
Héctor Corrada Bravo
Irina Astrovskaya
Joseph N Paulson
O Colin Stine
Richard I Walker
Subhra Chakraborty
P2860
P356
10.1186/S12864-016-2777-0
P407
P577
2016-06-08T00:00:00Z